Literature DB >> 24532192

Interval colorectal cancers: what and why.

Chantal M C le Clercq1, Silvia Sanduleanu.   

Abstract

An increasing number of studies now indicate that colonoscopic examination is not perfect in preventing colorectal cancer (CRC), especially of the proximal colon. Several factors can be implicated in the occurrence of interval CRCs--further referred to as postcolonoscopy CRCs-, such as missed, incompletely resected lesions and newly developed cancers. Missed lesions represent by far the dominant cause of postcolonoscopy CRCs, with nonpolypoid (flat or depressed) neoplasms and sessile serrated polyps playing a significant role. Molecular events underlying progression of such lesions may further augment the cancer risk. In this article, we review the literature about postcolonoscopy CRC risk and the most common explanations. We discuss potential implications, paying special attention to improvements required in education and training.

Entities:  

Mesh:

Year:  2014        PMID: 24532192     DOI: 10.1007/s11894-014-0375-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  68 in total

1.  Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential.

Authors:  Eveline J A Rondagh; Ad A M Masclee; Mirthe E van der Valk; Bjorn Winkens; Adriaan P de Bruïne; Tonya Kaltenbach; Roy M Soetikno; Silvia Sanduleanu
Journal:  Scand J Gastroenterol       Date:  2011-12-08       Impact factor: 2.423

2.  How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.

Authors:  Laura C Seeff; Thomas B Richards; Jean A Shapiro; Marion R Nadel; Diane L Manninen; Leslie S Given; Fred B Dong; Linda D Winges; Matthew T McKenna
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

3.  Accuracy of administrative claims data for polypectomy.

Authors:  Jonathan M Wyse; Lawrence Joseph; Alan N Barkun; Maida J Sewitch
Journal:  CMAJ       Date:  2011-06-13       Impact factor: 8.262

4.  Prevalence and predictors of interval colorectal cancers in medicare beneficiaries.

Authors:  Gregory S Cooper; Fang Xu; Jill S Barnholtz Sloan; Mark D Schluchter; Siran M Koroukian
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

Review 5.  Circumstances in which colonoscopy misses cancer.

Authors:  Linda Rabeneck; Lawrence F Paszat
Journal:  Frontline Gastroenterol       Date:  2010-04-01

6.  Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation.

Authors:  A Ferrández; M Navarro; M Díez; F Sopena; P Roncalés; M Polo-Tomas; R Sáinz; A Lanas
Journal:  Endoscopy       Date:  2010-10-19       Impact factor: 10.093

7.  Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer.

Authors:  Nancy N Baxter; Rinku Sutradhar; Shawn S Forbes; Lawrence F Paszat; Refik Saskin; Linda Rabeneck
Journal:  Gastroenterology       Date:  2010-09-18       Impact factor: 22.682

8.  Is BRAF mutation associated with interval colorectal cancers?

Authors:  Aasma Shaukat; Mustafa Arain; Bharat Thaygarajan; John H Bond; Mandeep Sawhney
Journal:  Dig Dis Sci       Date:  2010-03-19       Impact factor: 3.199

9.  Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia.

Authors:  Alan Moss; Michael J Bourke; Stephen J Williams; Luke F Hourigan; Gregor Brown; William Tam; Rajvinder Singh; Simon Zanati; Robert Y Chen; Karen Byth
Journal:  Gastroenterology       Date:  2011-03-08       Impact factor: 22.682

10.  Reasons for failure to diagnose colorectal carcinoma at colonoscopy.

Authors:  M Leaper; M J Johnston; M Barclay; B R Dobbs; F A Frizelle
Journal:  Endoscopy       Date:  2004-06       Impact factor: 10.093

View more
  8 in total

Review 1.  [Incidental findings in gastroscopy and colonoscopy].

Authors:  J W Rey; A Hoffman; A Rambow; R Kiesslich
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

2.  The incidence of post-colonoscopy colorectal cancer: a retrospective long-term cohort study using a colonoscopy database.

Authors:  Ayako Nakada; Ryota Niikura; Atsuo Yamada; Shuntaro Yoshida; Yoshihiro Hirata; Kazuhiko Koike
Journal:  Int J Colorectal Dis       Date:  2017-01-14       Impact factor: 2.571

3.  Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer.

Authors:  Jie Cheng; Zhong-Ze Fang; Kenjiro Nagaoka; Minoru Okamoto; Aijuan Qu; Naoki Tanaka; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2014-10-02       Impact factor: 4.030

Review 4.  Serrated neoplasia-role in colorectal carcinogenesis and clinical implications.

Authors:  Joep E G IJspeert; Louis Vermeulen; Gerrit A Meijer; Evelien Dekker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-12       Impact factor: 46.802

5.  Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.

Authors:  Esmée J Grobbee; Atija Kapidzic; Anneke J van Vuuren; Monique van Leerdam; Iris Lansdorp-Vogelaar; Caspar W N Looman; Marco J Bruno; Ernst J Kuipers; Manon C W Spaander
Journal:  Am J Gastroenterol       Date:  2015-06-09       Impact factor: 10.864

6.  Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study.

Authors:  Roel M M Bogie; Chantal M C le Clercq; Quirinus J M Voorham; Martijn Cordes; Daoud Sie; Christian Rausch; Evert van den Broek; Sara D J de Vries; Nicole C T van Grieken; Robert G Riedl; Prapto Sastrowijoto; Ernst-Jan Speel; Rein Vos; Bjorn Winkens; Manon van Engeland; Bauke Ylstra; Gerrit A Meijer; Ad A M Masclee; Beatriz Carvalho
Journal:  Br J Cancer       Date:  2021-12-15       Impact factor: 9.075

Review 7.  Serrated neoplasia pathway as an alternative route of colorectal cancer carcinogenesis.

Authors:  Soon Young Kim; Tae Il Kim
Journal:  Intest Res       Date:  2018-07-27

8.  Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.

Authors:  Theodore A Tollivoro; Christopher D Jensen; Amy R Marks; Wei K Zhao; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Ann G Zauber; Chyke A Doubeni; Theodore R Levin; Bruce Fireman; Charles P Quesenberry; Douglas A Corley
Journal:  Gastrointest Endosc       Date:  2018-08-23       Impact factor: 9.427

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.